Log In
Print this Print this

LentiGlobin gene therapy (BB305)

  Manage Alerts
Collapse Summary General Information
Company bluebird bio Inc.
DescriptionLentiviral vector encoding the human beta globin gene delivered into a patient's own hematopoietic stem cells in the bone marrow
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Lentivirus

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today